Oral Administration of Artemisone for the Treatment of Schistosomiasis: Formulation Challenges and In Vivo Efficacy
Artemisone is an innovative artemisinin derivative with applications in the treatment of malaria, schistosomiasis and other diseases. However, its low aqueous solubility and tendency to degrade after solubilisation limits the translation of this drug into clinical practice. We developed a self-micro...
Main Authors: | Johanna Zech, Daniel Gold, Nadeen Salaymeh, Netanel Cohen Sasson, Ithai Rabinowitch, Jacob Golenser, Karsten Mäder |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-06-01
|
Series: | Pharmaceutics |
Subjects: | |
Online Access: | https://www.mdpi.com/1999-4923/12/6/509 |
Similar Items
-
Treatment of Experimental Cerebral Malaria by Slow Release of Artemisone From Injectable Pasty Formulation
by: Jacob Golenser, et al.
Published: (2020-06-01) -
Formulation and characterization of lipid-based drug delivery system of raloxifene-microemulsion and self-microemulsifying drug delivery system
by: Hetal Thakkar, et al.
Published: (2011-01-01) -
Formulation and characterisation of self-microemulsifying drug delivery systems based on biocompatible nonionic surfactants
by: Đekić Ljiljana M., et al.
Published: (2014-01-01) -
Anti-Melanoma Activities of Artemisone and Prenylated Amino-Artemisinins in Combination With Known Anticancer Drugs
by: Ho Ning Wong, et al.
Published: (2020-09-01) -
Transdermal delivery of artemisinins for treatment of pre-clinical cerebral malaria
by: Johanna Zech, et al.
Published: (2021-08-01)